Clinical Trials Sponsored by Bremer Pharmacovigilance Service GmbH

Total 4 results

Dr. August Wolff GmbH & Co. KG Arzneimittel
Bremer Pharmacovigilance Service GmbH; PHARMALOG Institute for Clinical Research

Completed

Safety, Tolerability and Efficacy of Vaginal Suppository WO3191 in the Post-treatment of Bacterial Vaginosis

Vaginosis, Bacterial

Germany
Dr. August Wolff GmbH & Co. KG Arzneimittel
proDERM Institut für Angewandte Dermatologische Forschung GmbH; Bremer Pharmacovigilance...

Completed

Investigation of Efficacy and Tolerability of a Lactic Acid Containing Vaginal Suppository in Post-menopausal Women With VVA

Vulvovaginal Atrophy

Germany
Dr. August Wolff GmbH & Co. KG Arzneimittel
proDERM Institut für Angewandte Dermatologische Forschung GmbH; Bremer Pharmacovigilance... and other collaborators

Completed

Investigation of Non-inferiority of Treatment of Vulvovaginal Dryness With WO2085 Moisturising Cream in Comparison to a Cream With 0.1% Estriol

Vulvovaginal Atrophy

Germany, Switzerland
Prof. Dr. M. Dreyling (co-chairman)
ClinAssess GmbH; Klinikum der Universitaet Muenchen, Grosshadern; GELARC Service...

Unknown

Efficacy and Safety of R-HAD Alone or in Combination With Bortezomib in Patients With Relapsed or Refractory MCL ((R-HAD))

Mantle Cell Lymphoma

France, Germany

3

Subscribe